Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
StemCell ARTS is a specialized medical practice focused on regenerative medicine and non-surgical orthopedic treatments. The company provides advanced orthobiologic therapies, including Platelet Rich Plasma (PRP) and Bone Marrow Concentrate (BMC) stem cell injections, to address musculoskeletal conditions such as osteoarthritis and sports injuries. As a member of the National Spine and Pain Centers network and a Regenexx affiliate, the practice follows standardized protocols for the processing and precise delivery of autologous biologics. Their clinical team utilizes high-resolution ultrasound and fluoroscopic guidance to ensure accurate targeting of damaged tissues. StemCell ARTS offers patients a minimally invasive alternative to traditional orthopedic surgery, aiming to reduce pain and improve function through natural healing processes. The practice operates clinics in the Washington D.C. metropolitan area, serving a diverse patient population ranging from professional athletes to individuals with degenerative joint disease.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on StemCell ARTS.